|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Mar―14 |
European Society of Cardiology guidance for the management of cardiovascular disease during the pandemic and a focus on long COVID |
Filippo Crea |
2 |
[GO] |
2022―Feb―18 |
Not only lungs: COVID-19 hits platelets as well |
Dario Bongiovanni, Melissa Klug, Marco Valgimigli, Isabell Bernlochner |
3 |
[GO] |
2022―Feb―08 |
The association between neutrophil to lymphocyte ratio and echocardiographic parameters in hospitalised adults with COVID-19 - a retrospective analysis |
R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan |
4 |
[GO] |
2022―Feb―08 |
Demographic analysis and clinical outcomes of COVID-19 and myocardial infarction from a tertiary care centre in south India |
R Kongara, RAMESH Sankaran, T R Muralidharan, P Manokar, S Sadhanandham, S Nagendra Boopathy, et al. (+3) B Vinod Kumar, J V Balasubramaniyan, K Preetham |
5 |
[GO] |
2022―Feb―08 |
Palliative care for patients with cardiovascular disease and COVID-19 in a major referral hospital |
T Correa, A M S Simao, J V B Sobreira, F Yarshell, F B Anbar, R T De Carvalho |
6 |
[GO] |
2022―Feb―08 |
The association between transthoracic echocardiographic parameters and severity of COVID-19 in hospitalised adults - a retrospective analysis |
R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan |
7 |
[GO] |
2022―Feb―08 |
Symptomatology, prognosis and clinical findings of myocarditis as an adverse event of COVID-19 mRNA vaccine: a systematic review |
VIKASH Jaiswal, AKASH Jaiswal, NITYA Batra, D Mukherjee, R Ruchika, ANGELA Ishak, et al. (+4) U Maskey, GAZALA Hitawala, DAVID Song, YASAR Sattar |
8 |
[GO] |
2022―Feb―08 |
Impact of Covid-19 on cardiovascular clinics: are we ready for tele-medicine? |
M Mujtaba, FAISAL Khanzada, DANISH Qayyum, TAHIR Saghir, SHARF Buraro |
9 |
[GO] |
2022―Feb―08 |
Effectiveness of a home-based cardiovascular disease prevention program during the COVID-19 pandemic |
P Chockalingam, V Natarajan, T Sekar, A Rajaram, M M Yusuf, S Gunasekaran, et al. (+2) P G Nayar, V Chockalingam |
10 |
[GO] |
2022―Feb―08 |
Virtual medical research mentoring and collaboration: breaking the bounds of nationality during the COVID-19 pandemic |
J S K Chan, D H H Lau, E King, Y K L Shum, L Roever, T Liu, et al. (+9) K Ng, E C Dee, A Ciobanu, G Bazoukis, E Mahmoudi, D I Satti, K Jeevaratnam, A Baranchuk, G Tse |
11 |
[GO] |
2022―Feb―08 |
Impact of the anti-hypertensive diets virtual education towards knowledge, attitude, practice, and reduction of blood pressure during covid-19 pandemic |
A Andrianto, M Ardiana, A Yutha, B P D Khrisna, R A Nugraha, T S Putra, et al. (+5) A R Shahab, H Andrianto, I H Kikuko, A N Puspitasari, M R Hajjrin |
12 |
[GO] |
2022―Feb―08 |
Clinical manifestation and impact on management of acute coronary syndrome during covid-19 pandemic, lessons learnt from a tertiary care |
T Subburaja, K A Sambasivam, R Radhika, P Sankara Thiagarajan |
13 |
[GO] |
2022―Feb―08 |
Impact of the COVID-19 pandemic on cardiology services in the second year at a South Asian cardiac centre |
F A Cader, M M Haq, S R Khan |
14 |
[GO] |
2022―Feb―08 |
Early impact of COVID-19 pandemic on heart transplant volumes in Asia and Oceania: results from the Global Observatory on Donation and Transplantation (GODT) |
Y Manla, N Bader, G Bajwa, L Gobolos, F Alsindi, I Hamour, et al. (+2) H Ghalib, F Al Badarin |
15 |
[GO] |
2022―Feb―08 |
Correlation of cardiac biomarkers with computed tomography severity score in COVID-19 patients |
R Rivera, L Cuenza, T Razon-Cuenza |
16 |
[GO] |
2022―Feb―08 |
Anticoagulation practices and venous thromboembolism in COVID-19 patients in a Philippine tertiary hospital |
M Ramos |
17 |
[GO] |
2022―Feb―08 |
Thromboembolic complication among COVID-19 patients in the intensive care unit (ICU): a single-centre study from a Malaysian perspective |
H Zulkifly, F Mansor, I Abdul Halim Zaki, K S Eng, L C Kiok, T Ravi, et al. (+3) M Pathmanathan, S Abd Wahab, R Muda |
18 |
[GO] |
2022―Feb―08 |
Efficacy and safety of fondaparinux versus unfractionated heparin in patients hospitalised with severe COVID-19 pneumonia and coagulopathy: a randomised, open-label clinical trial |
L H Adrian, S A Hutomo, A D S Negari |
19 |
[GO] |
2022―Feb―08 |
Prevalence and predictors for high blood pressure during covid-19 vaccination in Thailand |
S Patamatamkul |
20 |
[GO] |
2022―Feb―08 |
Evaluation of outcome of Coronavirus disease 2019 patients receiving RAAS inhibitors (OCRAS study): a prospective observational study of Bangladeshi hypertensive patients |
A B D Majumder, M T Rahman, A K M Islam, M Ullah, M K Zaman, M A Reza, et al. (+9) M S Islam, R C Khan, M Z Rahman, M M Rahman, M A Awal, S Kabir, G K Paul, S Nasrin, S Zaman |
21 |
[GO] |
2022―Feb―08 |
Impact of SARS-CoV2 pandemic onto acute ST-elevation myocardial infarction care and patient outcomes in a large tertiary cardiac center |
D Yong, M A Sulong, M Sundarajoo, N Am Haris, M Y Low, K Kaniappan, A A Nuruddin |
22 |
[GO] |
2022―Feb―08 |
The role of STEMI integrated networking system based on tele-cardiology for reducing ischemic time and crossing wire time delayed during COVID 19 pandemic |
M Rizki Fadlan, S Anjarwani, M Saifur Rohman |
23 |
[GO] |
2022―Feb―08 |
A survey-based comparison of cardiovascular health risk behaviours in Indian men and women during the pandemic |
P Chockalingam, V Natarajan, T Sekar |
24 |
[GO] |
2021―Dec―31 |
Frequency and outcome of acute coronary syndrome during the Covid-19 pandemic |
R A Mousavi, C Wallmueller, P Stratil, G Pichler, F Piringer, G Delle Karth, A Schober |
25 |
[GO] |
2021―Dec―20 |
Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up |
|
26 |
[GO] |
2021―Oct―25 |
Impact of COVID-19 on angioplasty service and outcome of patients treated for critical limb ischaemia |
A Rodway, C Giltinan, A Dehghan-Nayeri, A Santos, M Stafford, M B Whyte, et al. (+7) C Allan, B Field, J Clark, F Pazos Casal, A Pankhania, T Loosemore, C Heiss |
27 |
[GO] |
2021―Oct―21 |
Stroke mechanisms associated with coronavirus disease (COVID-19) |
M Kruchinina, A A Gromov, V M Generalov, A V Rabko, V N Kruchinin |
28 |
[GO] |
2021―Oct―21 |
Echocardiogram in critically ill patients with COVID-19 |
B F O Gomes, T M B Silva, I R R Menezes, A S Azevedo, L S Peres, D F P Pereira, et al. (+9) G P Dutra, S A M Paula, B F S Mendes, J H P Nascimento, A L Cantisano, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
29 |
[GO] |
2021―Oct―21 |
Impact of high cardiovascular risk on hospital mortality in patients admitted to intensive care by COVID-19 |
B F O Gomes, T M B Silva, G P Dutra, A S Azevedo, D F P Pereira, L S Peres, et al. (+5) J H P Nascimento, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
30 |
[GO] |
2021―Oct―21 |
COVID-19 infection impact on cardiovascular and thrombotic events during acute phase and medium-term of the disease |
A Varela Lopez, L Diaz Argueso, C Broco Fernandez, C E Cacho Antonio, P J Antunez Muinos, O Otero Garcia, et al. (+9) V Jimenez Ramons, T Gonzalez Ferreiro, M Perez-Poza, M Bastos Fernandez, A Garcia Campos, A Varela Roman, J Lopez Pais, D Lopez Otero, J R Gonzalez Juanatey |
31 |
[GO] |
2021―Oct―21 |
Introduction of alternative rehabilitation method for the patients with cardiovascular diseases in conditions of the COVID-19 pandemic |
R V Nesterak, I P Vakaliuk, N V Yakymchyk, I Drapchak, N V Savchuk, V I Sovtus, et al. (+2) R S Grygoryshyn, S M Bardashevska |
32 |
[GO] |
2021―Oct―21 |
Cardiovascular evaluation with exercise testing using face mask during the COVID-19 pandemic |
H Ilarraza-Lomeli, J Rojano-Castillo, G Carazo-Vargas, P S Flores-Carrillo, C F Barrera-Ramirez, M D Rius-Suarez, H N Ortega-Aranda |
33 |
[GO] |
2021―Oct―21 |
The direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy |
D J Hammersley, R J Buchan, L Mach, R E Jones, B P Halliday, S K Prasad, et al. (+2) A Roberts, J S Ware |
34 |
[GO] |
2021―Oct―21 |
Impact of COVID-19 pandemic on surgical care of patients with acute aortic conditions |
X Yuan, U Rosendahl, G Asimakopoulos, C Quarto, B Rosser, J Gaer, et al. (+4) M Petrou, S Bhudia, T Bahrami, C Nienaber |
35 |
[GO] |
2021―Oct―21 |
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up |
V De Marzo, P Clavario, R Lotti, C Barbara, A Porcile, G Guglielmi, et al. (+6) C Russo, A J Autala, R Griffo, G Parati, U Corra', I Porto |
36 |
[GO] |
2021―Oct―21 |
Clinical outcomes in COVID-19 patients with in-hospital cardiac arrest - an insight from multi-centre data |
M Mughal, I Kaur, S Waxman, H Gandhi, M Kakadia, Z Khakwani, et al. (+9) A Okoh, K Shah, A Obaid, V Sirpal, S Azad, A Jaffery, H Jagdey, I Tawfik, M Alam |
37 |
[GO] |
2021―Oct―21 |
Are there any long-term cardio-pulmonary limitations of hospitalized Covid-19 patients? |
R Badr Eslam, C Binder-Rodriguez, A Iscel, J Niebauer, R A Mousavi, C Kronberger, et al. (+2) C Wenisch, D Bonderman |
38 |
[GO] |
2021―Oct―21 |
Comparison of echocardiographic parameters of patients with COVID-19 pneumonia in hospital and three months after discharge |
E Yaroslavskaya, D Krinochkin, N Shirokov, E Gultyaeva, V Garanina, A Mamarina, et al. (+4) N Osokina, E Gorbatenko, N Musikhina, T Petelina |
39 |
[GO] |
2021―Oct―21 |
Critical COVID-19 rarely associated with left ventricular systolic impairment |
E Nakou, R Fisher, C Tountas, E Corcoran, A Dhariwal, A Marvaki, et al. (+9) A Hua, K O'Gallagher, A Nabeebaccus, P Pearson, T Fonseca, A Osborne, C Vega, M Monaghan, A Papachristidis |
40 |
[GO] |
2021―Oct―21 |
Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: in the grasp of SARS-CoV-2? |
B K Lakatos, M Tokodi, A Fabian, Z Ladanyi, Z Eles, V Juhasz, et al. (+9) H Vago, N Sydo, E Csulak, A R Kiss, M Horvath, Z Gregor, O Kiss, B Merkely, A Kovacs |
41 |
[GO] |
2021―Oct―21 |
Impact of the first coronavirus-disease pandemic wave on cardiovascular admissions and sudden cardiac death rates in Greece |
E Pagourelias, V P Vassilikos, K Katsos, E Zaggelidou, N Raikos, S Tzikas, et al. (+9) C Tsavousoglou, A Kouparanis, A Anastasakis, G Kassimis, A Ziakas, G Sianos, H Karvounis, I Kanonidis, C Spiliopoulou |
42 |
[GO] |
2021―Oct―21 |
Myocardial injury in patients hospitalized for SARS-CoV19: a maker or a marker of prognosis? |
C Montalto, S Ghio, M Pagnesi, A Cappelletti, L Baldetti, E Baldi, et al. (+5) C Lombardi, L Lupi, M Metra, S Perlini, L Oltrona-Visconti |
43 |
[GO] |
2021―Oct―21 |
Discriminatory accuracy of the SOFA score for determining clinical decompensation in patients presenting with COVID-19 |
N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, et al. (+5) J Newman, D Patel, J Fareed, S Berg, A Darki |
44 |
[GO] |
2021―Oct―21 |
Prehospital period in patients with COVID-19 and community acquired pneumonia: age characteristics, cardiovascular comorbidity and pharmacotherapy during epidemic wave (the data of hospital registry) |
M Lukiyanov, S Y Martsevich, A A Pulin, N P Kutishenko, E Y Andreenko, V A Dindikova, et al. (+9) A N Makoveeva, E Y Okshina, N A Dmitrieva, O V Lerman, V P Voronina, A V Zagrebelnyy, V G Klyashtorny, O E Karpov, O M Drapkina |
45 |
[GO] |
2021―Oct―21 |
Echocardiography and ECG monitoring not very beneficial in COVID-19 follow-up even in long haulers |
M Radvan, M Kamenik, L Koc, E Bartecku, L Sykorova, P Kala |
46 |
[GO] |
2021―Oct―21 |
Predictors of clinical decompensation in patients presenting with COVID-19 in an urban hospital health system |
N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, et al. (+5) J Newman, D Patel, J Fareed, S Berg, A Darki |
47 |
[GO] |
2021―Oct―21 |
COVID-19 in pregnant women with heart diseases. Adverse maternal and fetal outcomes. Case series from InCor registry of Pregnancy and Heart Disease |
M R Kirschbaum, M S Devido, E Azeka, L M M F Demarchi, J S Santos, D V R Pinto, et al. (+4) L A Hajjar, F Tarasoutchi, M Park, W S Avila |
48 |
[GO] |
2021―Oct―21 |
Structure and predictors of repolarization disorders in patients with severe COVID-19 infection |
T D Danilevych, Y M Mostovoy, L V Rasputina |
49 |
[GO] |
2021―Oct―21 |
Closure of outpatient cardiac rehabilitation during the first COVID-19 lockdown in Austria in spring 2020 resulted in deteriorating physical exercise capacity: a mixed-methods study |
S T Kulnik, M Sareban, I Hoeppchen, S Droese, A Egger, J Gutenberg, et al. (+4) B Mayr, B Reich, D Wurhofer, J Niebauer |
50 |
[GO] |
2021―Oct―21 |
Levels of hypersensitive troponin T in the emergency department as a predictive factor of mortality for hospitalized COVID-19 patients |
Y P Pionnier, P D Denoel, A M Manara, K Brousmiche |
51 |
[GO] |
2021―Oct―21 |
Assessment of vascular endothelial function in COVID-19 patients |
H Mejia-Renteria, A Travieso, A Sagir, E Martinez-Gomez, A Carrascosa-Granada, I Nunez-Gil, et al. (+3) V Estrada, A Lerman, J Escaned |
52 |
[GO] |
2021―Oct―21 |
Previous psychiatric disorders and antipsychotic drugs in COVID-19 patients: early findings on possible worse outcome |
M Scarpone, M Bergami, E Cenko, R Bugiardini, E Poluzzi, O Manfrini |
53 |
[GO] |
2021―Oct―21 |
Psychological profile of COVID-19 pneumonia survivors three month after hospitalization |
E Yaroslavskaya, O Guskova, B Prilenskii, T Petelina |
54 |
[GO] |
2021―Oct―21 |
Laboratory indicators of inflammation and systolic function of the left and right ventricles in patients with cardiovascular disease who have undergone COVID-19-associated pneumonia |
N Musikhina, T Petelina, E Yaroslavskaya, D Krinochkin, N Shirokov, N Osokina, E Gorbatenko |
55 |
[GO] |
2021―Oct―21 |
Obesity strongly predicts COVID-19-related major clinical adverse events in Coptic Clergy |
M Y Henein, I Bytyci, R Nicoll, S Rafik, S Ayad, F Vanchari |
56 |
[GO] |
2021―Oct―21 |
Interventional cardiology in times of COVID-19: impact on a terciary centre |
A Azul Freitas, C Ferreira, S Martinho, V Goncalves, J Almeida, J Rosa, et al. (+3) G Campos, E Jorge, L Goncalves |
57 |
[GO] |
2021―Oct―21 |
Effect of body mass index on cardiac injury/cardiovascular outcomes in coronavirus disease 2019: a systematic review and meta-analysis |
M Ashraf, V Zlochiver, M S Rawala, M Dahar, J Robinson, M F Jan |
58 |
[GO] |
2021―Oct―21 |
Cardiac troponin as major mortality risk factor in SARS-CoV-2 infection |
A Gonzalez Leal, S Antonana Ugalde, A Arteagoitia Bolumburu, J M Monteagudo Ruiz, R R Martinez Moya, R Ortega Perez, et al. (+5) S Rivas Garcia, M A Sanroman Guerrero, A Lorente Ros, L M Rincon Diaz, J L Zamorano Gomez |
59 |
[GO] |
2021―Oct―21 |
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players |
S Fikenzer, A Kogel, P Hepp, D Lavall, S T Stoebe, U Rudolph, et al. (+2) U Laufs, A Hagendorff |
60 |
[GO] |
2021―Oct―21 |
The impact of anxiety level on medical decisions of non-COVID patients during the pandemic outbreak |
O Koren, S Abu Rajab, M Barbour, M Shachar, A Shahar, K Zubidat, et al. (+5) W Slim, D Igbariya, E Rozner, Y Turgeman, E Mader |
61 |
[GO] |
2021―Oct―20 |
Cardiac arrhythmias 3 months after hospitalization for COVID-19 |
C B Ingul, J Grimsmo, A Mecinaj, D Trebinjac, M Berger Nossen, S Andrup, et al. (+4) K Stavem, T Josefsen, T Omland, T Jensen |
62 |
[GO] |
2021―Oct―20 |
Impact of the COVID-19 pandemic on emergent pacemaker implantation during lockdown and its aftermath |
D De Almeida Fernandes, R Cadete, J Guimaraes, E Monteiro, G Costa, N Antonio, L Goncalves |
63 |
[GO] |
2021―Oct―20 |
Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease |
H Barman, A Atici, H O Arabaci, I Sahin, B Gungor, S M Dogan |
64 |
[GO] |
2021―Oct―20 |
Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination |
Filippo Crea |
65 |
[GO] |
2021―Oct―20 |
Impact of COVID-19 in adult patients with congenital heart disease |
I Cardoso, T B Branco, A Constante, J Martins, L Sousa, J Viegas, et al. (+2) T Rito, R C Ferreira |
66 |
[GO] |
2021―Oct―20 |
The impact of the COVID-19 pandemic on the management and outcomes of STEMI patients in Switzerland |
S Fournier, T Mahendiran, D Radovanovic, G Pedrazzini, F Eberli, M Roffi, et al. (+2) R Kobza, H Rickli |
67 |
[GO] |
2021―Oct―20 |
Comparison of D-dimer level measured on the third day of hospitalization with D-dimer level in predicting in-hospital mortality in COVID-19 patients |
M Selcuk, T Cinar, N Gunay, M Keskin, V Cicek, S Kilic, et al. (+2) S Asal, A L Orhan |
68 |
[GO] |
2021―Oct―20 |
Modified CHA2DS2-VASc can predict mortality in COVID-19 patients admitted to the emergency department |
B V Silva, C Jorge, C Mendonca, M L Urbano, T Rodrigues, P Silverio Antonio, et al. (+9) J Brito, P Alves Da Silva, B Garcia, C Martins, J Rigueira, I Ricardo Aguiar, M Nobre Menezes, R Placido, F J Pinto |
69 |
[GO] |
2021―Oct―20 |
Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines |
R Ong, C Chacon, S Javier |
70 |
[GO] |
2021―Oct―20 |
Impact of type 2 diabetes mellitus on clinical outcomes in patients with COVID-19 and cardiovascular disease |
K G Lobanova, T Y U Demidova, V M Plakhotnyaya |
71 |
[GO] |
2021―Oct―20 |
Outcomes of COVID-19 infection in heart transplant recipients |
D Miklin, A Mantha, A Wolfson, A Vaidya, E Depasquale |
72 |
[GO] |
2021―Oct―20 |
Impact of COVID-19 lockdown on the procedural and intra-hospital outcome of STEMI patients |
L Gaede, H Rittger, H Gerrens, A Achajew, N Schacher, P Ferstl, et al. (+4) M Troebs, M Arnold, M Marwan, S Achenbach |
73 |
[GO] |
2021―Oct―20 |
Impact of COVID-19 on heart failure hospitalizations: one year after |
R Gonzalez-Manzanares, G Heredia Campos, C Fernandez-Aviles Irache, A Resua Collazo, C Pericet-Rodriguez, I Gallo-Fernandez, et al. (+9) A Fernandez-Ruiz, L Carnero Montoro, M.J Oneto-Fernandez, A Luque-Moreno, N Paredes-Hurtado, D Pastor-Wulf, J Lopez-Baizan, J.C Castillo-Dominguez, M Anguita |
74 |
[GO] |
2021―Oct―20 |
Prehospital ECG in patients with acute myocardial infarction during the COVID-19 pandemic |
M Avvedimento, A Leone, A Spinelli, A Franzone, G Esposito, R Piccolo |
75 |
[GO] |
2021―Oct―20 |
Impact of telehealth in the outpatient management of atrial fibrillation during the COVID-19 pandemic |
I Shatla, Y Sammour, K Kennedy, A P Wimmer |
76 |
[GO] |
2021―Oct―20 |
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in Israel |
E Asher, A Fardman, D Zahger, K Orvin, M Mohsen, O Tsafrir, et al. (+9) R Rubinshtein, J Jamal, R Efraim, N Kofman, M Halabi, Y Shacham, L Henri Fortis, R Beigel, S Matetzky |
77 |
[GO] |
2021―Oct―20 |
Indirect effects of COVID-19 Pandemic in ST-segment elevation myocardial infarction: insights from a multicentric national survey |
H Pereira, R Cale, P Farto-Abreu, E Pereira, S S L On Behalf Of Stent Save A Life Initiative |
78 |
[GO] |
2021―Oct―20 |
Effects of remote monitoring of patients with heart failure based on smartphone application in the context of the COVID-19 pandemic in the Kyrgyz Republic |
A R Rustambekova, M R Djusupbekova, A A Moldobaeva, A I Moldomamatova, A M Noruzbaeva |
79 |
[GO] |
2021―Oct―20 |
Impact of the Covid-19 pandemic on the device therapy for patients with the heart failure |
R Hall, R Chattopadhyay, P.J Pugh |
80 |
[GO] |
2021―Oct―20 |
In-hospital predictors of 60-day readmission in COVID-19 patients |
M Ruge, A Gill, J M D Gomez, J Du Fay De Lavallaz, J A Simmons, K A Williams, et al. (+4) A S Volgman, K Marinescu, A Rao, T Suboc |
81 |
[GO] |
2021―Oct―20 |
The impact of daily troponin-I and D-dimer serum levels on mortality of moderate-to-severe COVID-19 pneumonia patients |
B Stavileci, E Ozdemir |
82 |
[GO] |
2021―Oct―20 |
Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure |
M Selcuk, M Keskin, T Cinar, N Gunay, S Dogan, V Cicek, et al. (+5) S Kilic, S Asal, S Yavuz, N Keser, A.L Orhan |
83 |
[GO] |
2021―Oct―20 |
Three-month cardiac outcomes of survivors of COVID-19 presenting to a district general hospital in West Hertfordshire, UK |
P K Pyae, A Navarra, R Webb, A Newland-Smith, R Vancheeswaran, J Sehmi, A Barlow |
84 |
[GO] |
2021―Oct―20 |
Biochemical and cardiovascular predictors of PIMS risk in children after COVID-19 recovery =- the results of the LATE COVID Kids study |
I Jatczak-Pawlik, J Lewek, E Czkwianianc, K Zeman, P Jankowski, M Banach |
85 |
[GO] |
2021―Oct―20 |
Hypertension as a prognostic factor in the prediction of mortality in patients with COVID-19: a systematic review and meta-analysis |
C D P Pagdanganan, J Juangco |
86 |
[GO] |
2021―Oct―20 |
Role of telemedicine network provided by pharmacies to detect acute myocardial infarction in patients with chest pain during coronavirus pandemia |
F Fioretti, M Piazzani, D S Cani, A Madureri, G F Gensini, F Gabbrielli, et al. (+3) G Bollani, F Glisenti, S Nodari |
87 |
[GO] |
2021―Oct―20 |
Cardiovascular predictors associated with poor short-term prognosis in patients diagnosed with SARS-CoV-2 in Spain |
L Esteban-Lucia, A Devesa-Arbiol, M A Zambrano Chacon, A M Venegas Rodriguez, M Gonzalez-Rodriguez, L Maure-Blesa, et al. (+9) P Avila-Barahona, A M Pello-Lazaro, O Gonzalez-Lorenzo, R Fernandez-Roblas, F Villar-Alvarez, B Ibanez, J Tunon, A Acena Navarro, J A Franco Pelaez |
88 |
[GO] |
2021―Oct―20 |
The surgical management of heart failure: heart transplantation in the era of SARS-CoV-2 pandemic |
J Malyszek, M Jasinska, M Zembala, K Ratman, B Krol, K Tkocz, et al. (+4) K Pelar, P Sybila, M Pajor, Z Nawrat |
89 |
[GO] |
2021―Oct―20 |
Sars-CoV2- infection as a trigger of humoral response against apolipoprotein A-1 |
S Pagano, S Yerly, N Suh, C Le Terrier, L Farrera-Soler, G Piumatti, et al. (+9) C S Eberhardt, C A Siegrist, I Eckerle, S Stringhini, I Guessous, L Kaiser, J Pugin, N Winssinger, N Vuilleumier |
90 |
[GO] |
2021―Oct―20 |
Post-COVID myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2-9 months after acute COVID-19 |
O Blagova, D H Ainetdinova, Y U A Lutokhina, V M Novosadov, R S Rud', A Y U Zaitsev, et al. (+3) A D Kukleva, S A Alexandrova, E A Kogan |
91 |
[GO] |
2021―Oct―20 |
Atrial fibrillation is associated with poor clinical trajectory of COVID-19 |
S.J Stjepan Jurisic, M.K Komminoth, B.W Wiggli, D.A.B Bertschi, P.K Koepfli, I.V Vranjic, et al. (+9) A.F Friedl, J.C Contartese, F.F Fontana, H.S Schmid, J.R Rutishauser, C.G Gebhard, A.T Todorov, J.B Beer, D Patriki |
92 |
[GO] |
2021―Oct―20 |
Cardiovascular outcomes in hospitalized patients with COVID-19 and history of cancer: a CORONA-VTE analysis |
C D Khairani, B M Barns, S M Rizzo, M B Pfeferman, J E Snyder, S Z Goldhaber, G Piazza |
93 |
[GO] |
2021―Oct―20 |
Increased incidence of Persistent Pulmonary Hypertension of the Newborn following third trimester maternal COVID-19 infection |
A Ishqeir, A Nir, I Aptowitzer, M Godfrey |
94 |
[GO] |
2021―Oct―20 |
Blood pressure changes during the the COVID-19 pandemic and associated lockdown period |
N Girerd, C Meune, K Duarte, V Vercamer, M Lopez-Sublet, J J Mourad |
95 |
[GO] |
2021―Oct―20 |
Combined cardiac risk factors predict COVID-19 related mortality and the need for mechanical ventilation in Coptic Clergy |
M Y Henein, I Bytyci, R Nicoll, R Sheneuda, S Ayad, M Cameli, F Vancheri |
96 |
[GO] |
2021―Oct―20 |
Meta-Analysis of COVID-19 treatments on patients with a previous diagnosis of cardiovascular disease |
S Ben-Aicha, J Buchanan, M Moscarelli, P Punjabi, C Emanueli |
97 |
[GO] |
2021―Oct―19 |
Atrial fibrillation as a risk factor of severe course of COVID-19 |
A Mielczarek, J D Kasprzak, M Plewka |
98 |
[GO] |
2021―Oct―19 |
The correlation of anti-heart antibodies levels with clinical manifestations and outcomes in patients with COVID-19 |
O Blagova, N V Varionchik, V A Zaidenov, P O Savina, N D Sarkisova |
99 |
[GO] |
2021―Oct―19 |
Erythrocytes induce vascular dysfunction in COVID-19 |
A Mahdi, A Collado, J Tengbom, T Jiao, T Wodaje, J Yang, et al. (+3) J O Lundberg, Z Zhou, J Pernow |
100 |
[GO] |
2021―Oct―19 |
Clinical effects of the enhanced external counterpulsation therapy in patients with ischemic chronic heart failure exacerbation COVID-19 |
I Shashenkov, S.A Gabrusenko, S.L Babak, A.G Maliavin |
101 |
[GO] |
2021―Oct―19 |
Prognostic value of atrial fibrillation in COVID-19 admitted patients |
A Santos Sanchez, P E Gonzalez-Recio, E Sanchez-Corral, J J Jimenez-Nacher |
102 |
[GO] |
2021―Oct―19 |
Frontal QRS/T angle can predict mortality in COVID-19 patients |
R Gunduz, B S Yildiz |
103 |
[GO] |
2021―Oct―19 |
Changes in health perception of COVID-19 among patients with aortic diseases: a longitudinal study between the first and second wave of the COVID-19 pandemic |
A Parys, S Klinge, A Doenmez, C Rammos, T Rassaf, A Janosi, J Lortz |
104 |
[GO] |
2021―Oct―19 |
Prospective analysis of inflammatory response markers, endothelial dysfunction and hemostasis parameters in COVID-19 associated pneumonia patients with and without type 2 diabetes mellitus |
T Petelina, N Musikhina, K Avdeeva, S Leonovich, L Gapon, E Gorbatenko, et al. (+6) Y Sharoyan, E Zueva, E Yaroslavskaya, E Gultyaeva, E Kalyuzhnaya, A Shcherbinina |
105 |
[GO] |
2021―Oct―19 |
Acute myocardial infarction in the Covid-19 era: incidence, clinical characteristics and in-hospital outcomes - a multicenter registry |
A Fardman, D Zahger, K Orvin, N Kofman, J Mohsen, O Tsafrir, et al. (+9) E Asher, R Rubinshtein, J Jamal, R Efraim, M Halabi, Y Shacham, L H Fortis, R Beigel, S Matetzky |
106 |
[GO] |
2021―Oct―19 |
Cardiac implantable electronic devices: a marker for poor outcome in patients with COVID-19 infection |
B Wizman, M Haim, N Yasoor, I Peles, V Novack, Y Konstantino |
107 |
[GO] |
2021―Oct―19 |
Arrhythmia patterns in patients with COVID-19 infection during and post hospitalization detected via a patch-based mobile cardiac telemetry system |
O Reynbakh, E D Braunstein, M Hsu, J Ellis, L Crosson, J Lenane, et al. (+3) A Krumerman, L Di Biase, K J Ferrick |
108 |
[GO] |
2021―Oct―19 |
Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: comparison to other types of severe pneumonia |
P Jirak, Z Shomanova, R Larbig, D Dankl, N Frank, C Seelmaier, et al. (+9) D Butkiene, M Lichtenauer, B Strohmer, J Sackarnd, U Hoppe, J Sindermann, H Reinecke, R Pistulli, L Motloch |
109 |
[GO] |
2021―Oct―19 |
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks |
D Trabattoni, G Teruzzi, P M Ravagnani, G Santagostino Baldi, P Montorsi, G Calligaris, et al. (+2) S Galli, A L Bartorelli |
110 |
[GO] |
2021―Oct―19 |
Stent-Save a Life international survey on the practice of primary coronary angioplasty during the COVID-19 pandemic |
H Pereira, S S L On Behalf Of Stent Save A Life Initative |
111 |
[GO] |
2021―Oct―19 |
STEMI patients in the first and second wave of COVID-19 pandemic in Slovenia |
A Sinkovic, M Krasevec, J Golub, D Suran, M Marinsek, A Markota |
112 |
[GO] |
2021―Oct―19 |
Feasibility of remote support for electrophysiological ablation procedures during CoVid-19 pandemics |
A Muessigbrodt, F Demoniere, S Finoly, M Mommarche, J Inamo |
113 |
[GO] |
2021―Oct―19 |
Dynamics of myocardial global longitudinal strain in patients with COVID-19 without significant baseline cardiovascular pathology |
S Iakovlev, O Dukhin, E Ryzhkova, E Andreeva, A Kalinskaya |
114 |
[GO] |
2021―Oct―19 |
Clinical and morphological characteristics of COVID-19-associated myocarditis |
E A Kogan, A D Kukleva, O V Blagova, Y U S Berezovskij |
115 |
[GO] |
2021―Oct―19 |
Cardiac arrest in patients hospitalized for COVID-19: a tertiary medical center retrospective cohort study |
S Luo, J M Du-Fay-De-Lavallaz, J M D Gomez, S Fugar, L Golemi, C J Chiang, et al. (+5) T Suboc, J A Simmons, K A Williams, A S Volgman, J Wasserlauf |
116 |
[GO] |
2021―Oct―19 |
Expressing a truncated SARS-COV-2 spike protein in mouse heart induces cardiac hypertrophy |
S Negron, C Kessinger, Z Lin |
117 |
[GO] |
2021―Oct―19 |
Novel SARS-CoV-2 variants induce higher toxicity in cardiovascular cells |
J U G Wagner, D Bojkova, M Shumliakivska, G S Aslan, J D Kandler, A Hansen, et al. (+5) J Krishnan, A M Zeiher, S Ciesek, J Cinatl, S Dimmeler |
118 |
[GO] |
2021―Oct―18 |
Cardiac function is normal in most patients recovered from COVID-19 |
J Tangen, P Aukrust, A Barrat-Due, M Troseid, I Christoffer Olsen, K Nezvalova-Henriksen, et al. (+9) T Kaasine, A M Dyrhol-Riise, A Rygh Holten, A K Finbraten, T A Josefsen, K C Lee, K H Haugaa, H Skulstad, T Edvardsen |
119 |
[GO] |
2021―Oct―18 |
Mid-term endothelial dysfunction post COVID-19 |
S Lampsas, E Oikonomou, G Siasos, N Souvaliotis, A Goliopoulou, C V Mistakidi, et al. (+6) P Theofilis, G Vogiatzi, K Kalogeras, E Katsianos, D Tousoulis, M Vavuranakis |
120 |
[GO] |
2021―Oct―18 |
The role of cardiovascular calcifications in COVID-19 |
M Toselli, A C Cereda, F G Giannini, A S Scoccia, G G Gallone, A P Palmisano, et al. (+2) D V Vignale, A E Esposito |
121 |
[GO] |
2021―Oct―18 |
Clinical and echocardiographic risk score predicts need for hospitalization among patients with COVID-19 |
J Kothari, K Shah, T Daly, P Saraiya, I Taha, M Le, et al. (+2) H Goel, J Shirani |
122 |
[GO] |
2021―Oct―18 |
Long-term post-discharge coagulation abnormalities in patients with moderate to severe COVID-19 |
G Artemyeva, A Kalinskaya, O Dukhin, A Lebedeva, A Rozin, A Shpektor, E Vasilieva |
123 |
[GO] |
2021―Oct―18 |
The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19 |
C Lee, N Patel, L Panepinto, M Byers, M Ambrosino, S Adusumalli, et al. (+3) S Denduluri, J Cohen, M Scherrer-Crosbie |
124 |
[GO] |
2021―Oct―18 |
Cardiac involvement in patients recovered from coronavirus disease-2019 (COVID-19): a systematic review |
N Shafiabadi, H Rastad, M Mozafarybazargany, H Talakoob, H Karim |
125 |
[GO] |
2021―Oct―18 |
Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms |
M P Cassar, A J Lewandowski, M Mahmod, C Xie, E M Tunnicliffe, N Petousi, et al. (+4) N P Talbot, D Holdsworth, S Neubauer, B Raman |
126 |
[GO] |
2021―Oct―18 |
Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin |
C K Kaufmann, A A Ahmed, M K Kassem, M F Freynhofer, B J Jaeger, G A Aicher, et al. (+8) S E Equiluz-Bruck, A S Spiel, F V Vafai-Tabrizi, M G Gschwantler, P F Fasching, J W Wojta, E G Giannitsis, K H Huber |
127 |
[GO] |
2021―Oct―18 |
Impact of COVID-19 disease on platelet reactivity and association with inflammatory parameters |
M Ascencio, M Munoz-Esquerre, Y Pascual, M Iglesias, J Sabater, O Murillo, et al. (+5) S G Sosa, J A Gomez-Hospital, S Santos, J Comin-Colet, J L Ferreiro |
128 |
[GO] |
2021―Oct―18 |
Echocardiographic markers of mortality at 60 days in patients with COVID-19 in the intensive care unit |
J Sprockel, J M Rincon, M Rondon, M Bejarano, N Castellanos, Z Santofimio, et al. (+4) H M Cardenas, D Hernandez, J E Parra, J J Diaztagle |
129 |
[GO] |
2021―Oct―18 |
Is endothelial dysfunction a driving force of COVID-19 induced coagulopathy? |
O Dukhin, A Kalinskaya, I Molodtsov, A Maltseva, D Sokorev, A Elizarova, et al. (+8) K Glebova, D Stonogina, S Shakhidzhanov, I Spiridonov, F Ataullakhanov, L Margolis, A Shpektor, E Vasilieva |
130 |
[GO] |
2021―Oct―18 |
Consequences on the right ventricular to pulmonary circulation coupling of COVID-19 infection |
A M Vella, F Bursi, G Santangelo, A Barbieri, F Toriello, F Valli, et al. (+3) D Sansalone, S Carugo, M Guazzi |
131 |
[GO] |
2021―Oct―18 |
Clinical impact on treatment and prognosis of advanced cardiac imaging with echocardiography in the acute setting of a COVID-19 infection |
M Gonzalez Del Hoyo, L Servato, R Fernandez-Galera, E Rodenas, M Garcia, G Casas, et al. (+9) P Jordan, L Herrador, M Bach, F Valente, L Gutierrez, J Baneras, A Evangelista, I Ferreira, J Rodriguez-Palomares |
132 |
[GO] |
2021―Oct―18 |
Stress myocardial blood flow reduced after severe COVID-19, not related to symptoms |
P Doeblin, C Goetze, S Al-Tabatabaee, A Berger, F Steinbeis, M Witzenrath, et al. (+7) A Faragli, C Stehning, A Chiribiri, C M Scannell, E Alskaf, B Pieske, S Kelle |
133 |
[GO] |
2021―Oct―18 |
Prognostic value of coronary artery calcium score in hospitalized COVID-19 patients |
A Motoc, M L Luchian, S Lochy, D Belsack, J Magne, B Roosens, et al. (+9) J De Mey, S Boeckstaens, K Van Den Bussche, B Von Kemp, X Galloo, C Francois, C Weytjens, S Droogmans, B Cosyns |
134 |
[GO] |
2021―Oct―18 |
Pocket-size ultrasound devices may improve the prompt assessment of Covid-19 patients |
D Filipiak, J D Kasprzak, P Lipiec |
135 |
[GO] |
2021―Oct―18 |
Preponderance of right ventricular dysfunction in COVID-19 patients with inflammatory heart disease |
S T Thodeti, D S L Lattanzio, T M K Kuraan, M U K Khalid, D D Drenic, R S R Raghupathy, et al. (+2) S V V Vallabhaneni, J R M Mikolich |
136 |
[GO] |
2021―Oct―18 |
Initial COVID-19 symptoms are not predictive of post-COVID recovery inflammatory heart disease detected by cardiac MRI |
S T Thodeti, D S L Lattanzio, D D Drenic, T M K Kuraan, M U K Khalid, S V V Vallabhaneni, J R M Mikolich |
137 |
[GO] |
2021―Oct―18 |
Association between cardiac pathology and outcomes of patients with COVID-19 using a hand-held ultrasound |
Z Dadon, N Levi, A Orlev, D Belman, E A Alpert, Y Steinmetz, et al. (+4) A Wolak, M Glikson, S Gottlieb, A Butnaru |
138 |
[GO] |
2021―Oct―18 |
Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals |
P Malerba, C Agabiti Rosei, M Nardin, A Gaggero, G Chiarini, C Rossini, et al. (+6) F Fama', V Brami, M A Coschignano, M L Muiesan, D Rizzoni, C De Ciuceis |
139 |
[GO] |
2021―Oct―18 |
Cytokine storm induced coagulopathy in septic shock and critical Covid-19: head-to-head comparison |
M D M Dechamps, J De Poortere, P F Laterre, M Octave, A Ginion, V Robaux, et al. (+9) J Bodart, D Gruson, M Van Dievoet, J Douxfils, M Derive, A Campion, M Martin, S Horman, C Beauloye |
140 |
[GO] |
2021―Oct―18 |
Can echocardiographic parameters predict mortality in COVID-19? |
A Babu, N Eden, Z Meng, D Lamb, R Bhatia, V Voon |
141 |
[GO] |
2021―Oct―18 |
Echocardiographic parameters as predictors of three-months mortality in patients with 2019 Coronavirus infection |
T Miranda Aquino, J M Pereira-Forcado, B Ordonez-Salazar, G Dominguez-Trejo, A Rangel-Guerra, J Martinez-Castillo, et al. (+6) R J Vazquez-Orozco, A P Guevara-Canseco, S E Perez-Topete, R Aceves-Millan, L Amezcua-Gomez, C Ixcamparij-Rosales |
142 |
[GO] |
2021―Oct―18 |
Clinical characteristics and in-hospital outcomes of patients coinfected with Chagas disease and SARS-CoV-2 |
M Marcolino, I Molina, M C Pires, L E F Ramos, R T Silva, M H Guimaraes Junior, et al. (+9) R L R Carvalho, A L R M Barros, A L Ribeiro, H Duani, F Anschau, F A Botoni, N R Oliveira, C A Polanczyk, M C P Nunes |
143 |
[GO] |
2021―Oct―18 |
The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling |
E Avolio, M Carrabba, M Kavanagh Williamson, R Milligan, K Gupta, M Gamez, et al. (+6) R Foster, I Berger, M Caputo, A Davidson, D Hill, P Madeddu |
144 |
[GO] |
2021―Sep―23 |
Transforming community cardiology practice to virtual visits: innovation at Cleveland Clinic during the COVID-19 pandemic |
Gautam V Shah, Ankur Kalra, Umesh N Khot |
145 |
[GO] |
2021―Aug―11 |
The 2020 Olympic/Paralympic Games and Covid-19 in Japan |
Hiroaki Shimokawa |
146 |
[GO] |
2021―Aug―06 |
Can the US COVID-19 Response Advance Equity in Cardiovascular Health? |
Erica S Spatz, Adam L Beckman, Oyere K Onuma, Elias Mossialos |
147 |
[GO] |
2021―Jun―28 |
Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre |
Mattia Lunardi, Darren Mylotte, William Wijns, Yoshinobu Onuma, Osama Soliman, Patrick W Serruys, Faisal Sharif |
148 |
[GO] |
2021―May―29 |
COVID-19 and the heart: insights from the National Societies of Cardiology Journals |
Jean-Jacques Monsuez |
149 |
[GO] |
2021―May―13 |
Cardio Egypt 2021: one of the first physical meetings in the era of Covid-19 |
Magdy Abdelhamid, Mohamed Osama, Khaled Shokry |
150 |
[GO] |
2021―May―08 |
The ongoing impact of COVID-19 on cardiovascular care |
Mark Nicholls |
151 |
[GO] |
2021―Apr―16 |
Old and new enemies: psychological stress, occupational stress, COVID-19, and a glimpse of the future |
Filippo Crea |
152 |
[GO] |
2021―Apr―07 |
Erratum to: Conducting Clinical Trials in Heart Failure During (and After) the COVID-19 Pandemic: An Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) |
|
153 |
[GO] |
2021―Apr―06 |
Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19 |
Ulf Landmesser, Irina Lehmann, Roland Eils |
154 |
[GO] |
2021―Mar―26 |
COVID-19 and Emissions: An Opportunity for Sustainable Global Health |
Sanjay Rajagopalan, Robert B Jackson, Jagat Narula |
155 |
[GO] |
2021―Mar―26 |
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target? |
Mark B Pepys |
156 |
[GO] |
2021―Feb―05 |
Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic |
Filippo Crea |
157 |
[GO] |
2021―Feb―04 |
Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences |
Eloi Marijon, Nicole Karam, Xavier Jouven |
158 |
[GO] |
2020―Dec―10 |
Innovation in transforming a large-scale scientific medical conference in China entirely online in response to COVID-19 |
Jianping Li, Yuxi Li, Yong Huo |
159 |
[GO] |
2020―Nov―29 |
Rheumatic heart disease and COVID-19 |
Andrea Beaton, Liesl Zühlke, Jeremiah Mwangi, Kathryn A Taubert |
160 |
[GO] |
2020―Nov―28 |
Response to COVID-19 in a large academic Centre in South Africa |
Ntobeko A B Ntusi |
161 |
[GO] |
2020―Oct―30 |
COVID-19 pandemic: a sentiment analysis |
Ashish Kumar, Safi U Khan, Ankur Kalra |
162 |
[GO] |
2020―Oct―16 |
The effects of COVID-19 on general cardiology in Italy |
Carmen Anna Maria Spaccarotella, Salvatore De Rosa, Ciro Indolfi |
163 |
[GO] |
2020―Oct―12 |
The stethoscope: a potential vector for COVID-19? |
Rajiv S Vasudevan, Khalid Bin Thani, Dhuha Aljawder, Samantha Maisel, Alan S Maisel |
164 |
[GO] |
2020―Sep―18 |
Virtual medical education during the COVID-19 pandemic: how to make it work |
Amr Idris, Basel Edris |
165 |
[GO] |
2020―Sep―07 |
Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient |
Eva Toth, Luke Dancy, George Amin-Youssef, Alexandros Papachristidis, Rafal Dworakowski |
166 |
[GO] |
2020―Sep―03 |
Understanding COVID-19: in the end it is the endothelium-what else? |
Thomas F Lüscher |
167 |
[GO] |
2020―Jul―22 |
COVID-19 and cardiovascular disease |
Mark Nicholls |
168 |
[GO] |
2020―Jul―08 |
Acute coronary syndromes in developing countries during the COVID-19 pandemic |
Karim Said, Yasser El-Baghdady, Mohamed Abdel-Ghany |
169 |
[GO] |
2020―Jul―05 |
COVID-19 testing |
Roberto Ferrari, Marco De Angelis |
170 |
[GO] |
2020―Jun―20 |
Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation |
Dan Hu, Kan Liu, Bixi Li, Zhenhong Hu |
171 |
[GO] |
2020―Jun―17 |
EHRA 2020 during COVID-19 days |
Haran Burri, Katja Zeppenfeld, Hein Heidbuchel |
172 |
[GO] |
2020―Jun―17 |
Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic? |
Alan G Fraser, Piotr Szymański, Elizabeth Macintyre, Martin Landray |
173 |
[GO] |
2020―Jun―15 |
COVID-19 pandemic in India |
Venkata S Ram, Giridhara R Babu, Dorairaj Prabhakaran |
174 |
[GO] |
2020―Jun―14 |
COVID-19 and Katrina: recalcitrant racial disparities |
Harriette G C Van Spall, Clyde W Yancy, Keith C Ferdinand |
175 |
[GO] |
2020―Jun―08 |
The saga continues: is COVID-19 a cardiopulmonary disease? |
Thomas F Lüscher |
176 |
[GO] |
2020―Jun―06 |
COVID-19 and the healthcare workers |
Ankur Kalra, Erin D Michos, Kavitha M Chinnaiyan |
177 |
[GO] |
2020―Jun―03 |
Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs |
Luis M Ruilope, Juan Tamargo, Gema Ruiz-Hurtado |
178 |
[GO] |
2020―May―28 |
Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations |
Petr Widimsky, Jiri Benes, Alexander M Celko |
179 |
[GO] |
2020―May―25 |
Acute coronary syndromes during COVID-19 |
Serafina Valente, Francesca Anselmi, Matteo Cameli |
180 |
[GO] |
2020―May―25 |
Myocardial injury in severe COVID-19 infection |
Allan S Jaffe, John G F Cleland, Hugo A Katus |
181 |
[GO] |
2020―May―20 |
The ‘Black Death’ and the physician at the time of COVID-19 |
Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
182 |
[GO] |
2020―May―16 |
COVID-19: (mis)managing an announced Black Swan |
Thomas F Lüscher |
183 |
[GO] |
2020―May―14 |
Changes in the work mode of cardiologists during the COVID-19 epidemic in Wuhan |
Xiang Cheng, Changsheng Ma, Yaling Han |
184 |
[GO] |
2020―May―08 |
COVID-19 and congenital heart disease in perspective |
Michael A Gatzoulis |
185 |
[GO] |
2020―May―08 |
SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome |
Jorge Solano-López, Angel Sánchez-Recalde, José Luis Zamorano |
186 |
[GO] |
2020―May―07 |
TeleCheck-AF for COVID-19 |
Dominik Linz, Nikki A H A Pluymaekers, Jeroen M Hendriks |
187 |
[GO] |
2020―May―07 |
What COVID-19 is taking away from us |
Massimo Mapelli |
188 |
[GO] |
2020―May―07 |
Trying times for heart failure trials during the COVID-19 pandemic |
Judy Ozkan |
189 |
[GO] |
2020―May―07 |
The Certificate of Advanced Studies (CAS) course adapted to a pandemic |
Francesco Maisano, Agnes Bäker, Maurizio Taramasso, Barbara Jenny, Luca Vicentini, Victoria Jenkins, et al. (+4) Martin Andreas, Alberto Pozzoli, Michel Zuber, Carlos A Mestres |
190 |
[GO] |
2020―May―06 |
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19 |
Gavin Y Oudit, Marc A Pfeffer |
191 |
[GO] |
2020―May―06 |
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy |
Riccardo M Inciardi, Marianna Adamo, Laura Lupi, Dario S Cani, Mattia Di Pasquale, Daniela Tomasoni, et al. (+16) Leonardo Italia, Gregorio Zaccone, Chiara Tedino, Davide Fabbricatore, Antonio Curnis, Pompilio Faggiano, Elio Gorga, Carlo M Lombardi, Giuseppe Milesi, Enrico Vizzardi, Marco Volpini, Savina Nodari, Claudia Specchia, Roberto Maroldi, Michela Bezzi, Marco Metra |
192 |
[GO] |
2020―May―06 |
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic |
Alaide Chieffo, Giulio G Stefanini, Susanna Price, Emanuele Barbato, Giuseppe Tarantini, Nicole Karam, et al. (+14) Raul Moreno, Gill Louise Buchanan, Martine Gilard, Sigrun Halvorsen, Kurt Huber, Stefan James, Franz-Josef Neumann, Helge Möllmann, Marco Roffi, Guido Tavazzi, Josepa Mauri Ferré, Stephan Windecker, Dariusz Dudek, Andreas Baumbach |
193 |
[GO] |
2020―May―06 |
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 |
Shaobo Shi, Mu Qin, Yuli Cai, Tao Liu, Bo Shen, Fan Yang, et al. (+7) Sheng Cao, Xu Liu, Yaozu Xiang, Qinyan Zhao, He Huang, Bo Yang, Congxin Huang |
194 |
[GO] |
2020―Apr―30 |
The battle against COVID-19: mortality in Italy |
Roberto Ferrari, Aldo P Maggioni, Luigi Tavazzi, Claudio Rapezzi |
195 |
[GO] |
2020―Apr―28 |
Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients? |
Ruihai Zhou |
196 |
[GO] |
2020―Apr―27 |
A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience |
Yaling Han |
197 |
[GO] |
2020―Apr―22 |
Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective |
Paul Carter, Michael Anderson, Elias Mossialos |
198 |
[GO] |
2020―Apr―18 |
Fulminant myocarditis in the time of coronavirus |
Vittoria Cuomo, Roberta Esposito, Ciro Santoro |
199 |
[GO] |
2020―Apr―15 |
Key words to be adopted for COVID-19 research |
Aldo Maggioni, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
200 |
[GO] |
2020―Apr―13 |
Call to action for the cardiovascular side of COVID-19 |
Costanza Emanueli, Lina Badimon, Fabio Martelli, Ines Potočnjak, Irina Carpusca, Emma L Robinson, Yvan Devaux |
201 |
[GO] |
2020―Apr―13 |
Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis |
Thadathilankal-Jess John, Karim Hassan, Hellmuth Weich |
202 |
[GO] |
2020―Apr―13 |
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts |
Luka Nicin, Wesley Tyler Abplanalp, Hannah Mellentin, Badder Kattih, Lukas Tombor, David John, et al. (+8) Jan D Schmitto, Jörg Heineke, Fabian Emrich, Mani Arsalan, Tomas Holubec, Thomas Walther, Andreas M Zeiher, Stefanie Dimmeler |
203 |
[GO] |
2020―Apr―08 |
CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic |
Marijke Linschoten and, Folkert W Asselbergs |
204 |
[GO] |
2020―Apr―08 |
Priorities for Cath labs in the COVID-19 tsunami |
Gianluca Campo, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
205 |
[GO] |
2020―Apr―08 |
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage |
Bernhard Metzler, Peter Siostrzonek, Ronald K Binder, Axel Bauer, Sebastian Johannes Reinstadler |
206 |
[GO] |
2020―Apr―07 |
Transient complete heart block in a patient with critical COVID-19 |
Mona Azarkish, Vahideh Laleh far, Masoud Eslami, Reza Mollazadeh |
207 |
[GO] |
2020―Apr―07 |
Strategies to control COVID-19 and future pandemics in Africa and around the globe |
Anouar Fanidi, Xavier Jouven, Bamba Gaye |
208 |
[GO] |
2020―Apr―07 |
COVID-19 experience in Bergamo, Italy |
Michele Senni |
209 |
[GO] |
2020―Apr―07 |
Denominator matters in estimating COVID-19 mortality rates |
Bamba Gaye, Anouar Fanidi, Xavier Jouven |
210 |
[GO] |
2020―Apr―07 |
Typical takotsubo syndrome triggered by SARS-CoV-2 infection |
Philippe Meyer, Sophie Degrauwe, Christian Van Delden, Jelena-Rima Ghadri, Christian Templin |
211 |
[GO] |
2020―Apr―03 |
COVID-19-related myocarditis in a 21-year-old female patient |
In-Cheol Kim, Jin Young Kim, Hyun Ah Kim, Seongwook Han |
212 |
[GO] |
2020―Apr―01 |
The Cardiologist at the time of Coronavirus: a perfect storm |
Claudio Rapezzi, Roberto Ferrari |
213 |
[GO] |
2020―Mar―31 |
Initial COVID-19 affecting cardiac patients in China |
Yaling Han |
214 |
[GO] |
2020―Mar―30 |
Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by ‘on the scene’ cardiologists |
Lin Zhang, Yongzhen Fan, Zhibing Lu |
215 |
[GO] |
2020―Mar―25 |
Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
Gian Battista Danzi, Marco Loffi, Gianluca Galeazzi, Elisa Gherbesi |
216 |
[GO] |
2020―Mar―24 |
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 |
Alina Hua, Kevin O’Gallagher, Daniel Sado, Jonathan Byrne |
217 |
[GO] |
2020―Mar―19 |
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? |
Gabriela M Kuster, Otmar Pfister, Thilo Burkard, Qian Zhou, Raphael Twerenbold, Philip Haaf, et al. (+2) Andreas F Widmer, Stefan Osswald |
218 |
[GO] |
2020―Mar―13 |
Coronaviruses and the cardiovascular system: acute and long-term implications |
Tian-Yuan Xiong, Simon Redwood, Bernard Prendergast, Mao Chen |
219 |
[GO] |
2020―Mar―06 |
Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin |
Hongde Hu, Fenglian Ma, Xin Wei, Yuan Fang |